Literature DB >> 11330651

Evaluation of nitric oxide synthase and arginase in the induction of a Peyronie's-like condition in the rat.

T J Bivalacqua1, H C Champion, S Leungwattanakij, D Y Yang, J S Hyun, A B Abdel-Mageed, S C Sikka, P J Kadowitz, W J Hellstrom.   

Abstract

Peyronie's disease is an idiopathic, localized connective tissue disorder of the penis, involving the tunica albuginea of the corpus cavernosum and adjacent areolar space. Current proposals as to the origin of Peyronie's disease suggest that fibrosis and collagen changes of the tunica are the result of an inflammatory process following vascular trauma. Our laboratory and other investigators have recently proposed an animal model for the study of Peyronie's disease. When transforming growth factor-beta1 (TGF-beta1) was injected into the rat tunica albuginea, tissue fibrosis was observed at 6 weeks. Therefore, our aim was to assess arginase II, endothelial and inducible nitric oxide synthase isoforms, and nitrotyrosine levels--all factors involved in inflammatory reactions--in the cavernosal tissue of saline-injected and TGF-beta1-injected rats after 6 weeks in order to evaluate the roles these enzymes may play in the induction of a Peyronie's-like condition in the rat. To examine the expression of endothelial nitric oxide synthase (eNOS), iNOS, and arginase II protein, and mRNA in the corpus cavernosum, immunoblot analysis, and reverse transcriptase-polymerase chain reaction were performed. We also determined immunohistochemically the expression of nitrotyrosine, a marker of peroxynitrite formation, in the rat penis. After 6 weeks, iNOS protein and gene expression was up-regulated and eNOS protein and gene expression was down-regulated in the corpora cavernosa of the TGF-beta1-injected penises. Furthermore, arginase II protein expression as well as immunohistochemical localization of nitrotyrosine was significantly higher in the TGF-beta1-injected corpora cavernosa. These results suggest that iNOS is the key control element for peroxynitrite formation, arginase II expression, and eNOS down-regulation in the induction of a Peyronie's-like condition in the rat.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11330651

Source DB:  PubMed          Journal:  J Androl        ISSN: 0196-3635


  8 in total

1.  Chronic oral administration of the arginase inhibitor 2(S)-amino-6-boronohexanoic acid (ABH) improves erectile function in aged rats.

Authors:  Robert Segal; Johanna L Hannan; Xiaopu Liu; Omer Kutlu; Arthur L Burnett; Hunter C Champion; Jae Hyung Kim; Jochen Steppan; Dan E Berkowitz; Trinity J Bivalacqua
Journal:  J Androl       Date:  2012-04-05

2.  Antioxidant Mechanism of Xiaojin Pill () for Treatment of Peyronie's Disease in Rats Based on Matrix Metalloproteinases.

Authors:  Qiang Geng; Fu Wang; Qiang Han; Shao-Feng Chen; Bin Ouyang; Zhong Li; Yu Zhao; Qing-He Gao; Guo-Jin Yu; Jun Guo
Journal:  Chin J Integr Med       Date:  2019-10-24       Impact factor: 1.978

Review 3.  Priapism: new concepts in the pathophysiology and new treatment strategies.

Authors:  Trinity J Bivalacqua; Arthur L Burnett
Journal:  Curr Urol Rep       Date:  2006-11       Impact factor: 2.862

Review 4.  Peyronie's disease: a literature review on epidemiology, genetics, pathophysiology, diagnosis and work-up.

Authors:  Sultan Al-Thakafi; Naif Al-Hathal
Journal:  Transl Androl Urol       Date:  2016-06

Review 5.  Recent Pathophysiological Aspects of Peyronie's Disease: Role of Free Radicals, Rationale, and Therapeutic Implications for Antioxidant Treatment-Literature Review.

Authors:  Gianni Paulis; Gennaro Romano; Luca Paulis; Davide Barletta
Journal:  Adv Urol       Date:  2017-07-04

Review 6.  New discoveries in the basic science understanding of Peyronie's disease.

Authors:  Mark Jalkut; Nestor Gonzalez-Cadavid; Jacob Rajfer
Journal:  Curr Urol Rep       Date:  2004-12       Impact factor: 2.862

Review 7.  The pathophysiology of Peyronie's disease.

Authors:  Ahmed I El-Sakka; Emre Salabas; Murat Dinçer; Ates Kadioglu
Journal:  Arab J Urol       Date:  2013-08-07

Review 8.  Reversion of penile fibrosis: Current information and a new horizon.

Authors:  Ahmed I El-Sakka
Journal:  Arab J Urol       Date:  2011-05-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.